Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gossamer Bio Inc.

1.36
0.0000
Post-market: 1.370.0100+0.74%19:30 EDT
Volume:696.09K
Turnover:956.93K
Market Cap:309.13M
PE:-6.01
High:1.40
Open:1.34
Low:1.34
Close:1.36
Loading ...
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 17, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2020

Major Issues Report

8-K - Current report
Jul 02, 2020

Major Issues Report

8-K - Current report
Jun 18, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 21, 2020

Major Issues Report

8-K - Current report
May 19, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 18, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2020

Major Issues Report

8-K - Current report
Mar 24, 2020

Major Issues Report

8-K - Current report